SEC Form 4 · accession 0001773152-26-000003
ANI PHARMACEUTICALS INC · ANIP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Matthew J Leonard
Director
Period of report
May 21, 2026
Accepted (ET)
Jun 10, 2026 · 9:08 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001023024
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 21, 2026 | A | 4,357 | $0.00 | A | 11,221 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents a restricted stock award that will vest in full on May 21, 2027.